|
| 3-[1-[5-(cyclopropylamino)-5-oxopentyl]triazol-4-yl]-6-hydroxy-2-phenyl-1-benzofuran-5-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Huang Z, et al. 2010. Chem Biol Drug Des |
|
| 3-[1-[5-[(1-benzylpiperidin-4-yl)amino]-5-oxopentyl]triazol-4-yl]-6-hydroxy-2-phenyl-1-benzofuran-5-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Huang Z, et al. 2010. Chem Biol Drug Des |
|
| 3,3'-(1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn]-3,8-phenanthroline-2,7-diyl)dipropanoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Eriksson J, et al. 2012. Adv Exp Med Biol |
|
| 4,4-difluoro-1,7-dihydroxy-1,7-diphenylhepta-1,6-diene-3,5-dione |
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Kauppi AM, et al. 2003. Chem Biol |
|
| 4,4'-Thiobis(3-Methylphenol) |
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Pan NJ, et al. 2009. Antimicrob Agents Chemother |
|
| 4-[(E)-2-[5-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]-2-methyltetrazolo[1,5-a]pyrimidin-8-ium-7-yl]ethenyl]-N,N-dimethylaniline |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| 4-[1,3-dioxo-5-(4-oxo-4H-3,1-benzoxazin-2-yl)-1,3-dihydro-2H-isoindol-2-yl]benzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| 4-(4,5-Di([1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)benzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| 4-[5-(Hexahydro-4,6-dioxo-2-thioxopyrimidine-5-ylidenemethyl)-2-furanyl]-2-hydroxybenzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Tautz L, et al. 2005. J Biol Chem |
|
| 4-{N'-[3-(4-Nitro-phenyl)-5-oxo-1-thiocarbamoyl-1,5-dihydro-pyrazol-4-ylidene]-h |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| | | |
